6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Regencell Bioscience Holdings Ltd
Filed: February 16, 2022
Period of Report: February 16, 2022
Accession Number: 0001213900-22-008083

View Document ↗ View on SEC.gov ↗